Literature DB >> 11762147

Pancreaticoduodenectomy as treatment of adenocarcinoma of the papilla of Vater diagnosed during pregnancy. A case report.

R Ruano1, E A Hase, C Bernini, D S Steinman, D Birolini, M Zugaib.   

Abstract

BACKGROUND: Papillary adenocarcinomas are rare tumors of the gastrointestinal tract. There are few reports of this neoplasm diagnosed during pregnancy. CASE: A case of adenocarcinoma of the papilla of Vater was diagnosed by sonographically guided biopsy during pregnancy. The patient underwent radical resection of the tumor at 25 weeks' gestation; pregnancy termination was not indicated. At 39 weeks' gestation, a cesarean-section was performed. The postoperative period entailed total parenteral nutrition until intestinal motility stabilized. This ensured the mother and fetus' well-being until delivery.
CONCLUSION: Papillary adenocarcinoma is associated with good prognosis since it is totally removed by radical resection, and pancreaticoduodenectomy can be performed successfully during pregnancy, but the patient must receive special prenatal care.

Entities:  

Mesh:

Year:  2001        PMID: 11762147

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

1.  A 37 year-old pregnant woman with pancreatic adeno-carcinoma treated with surgery and adjuvant chemotherapy: A case report and literature review.

Authors:  S Lubner; B Hall; Dv Gopal; A Soni; R Hegeman; N Winterle; A Loeffler; S Weber; Sb Reeder; N Loconte
Journal:  J Gastrointest Oncol       Date:  2011-12

Review 2.  Pancreatic adenocarcinoma in the pregnant patient: a case report and literature review.

Authors:  Rose M Kakoza; Charles M Vollmer; Keith E Stuart; Tamara Takoudes; Douglas W Hanto
Journal:  J Gastrointest Surg       Date:  2008-09-25       Impact factor: 3.452

3.  Non-functioning, malignant pancreatic neuroendocrine tumour (PNET): a rare entity during pregnancy.

Authors:  Carsten H Kamphues; Christoph Röcken; Peter Neuhaus; Ulf P Neumann
Journal:  Langenbecks Arch Surg       Date:  2008-05-30       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.